-
Glioblastoma Multiforme Treatment (GBM) Market (2021): Production Growth, Threats & Challenges, Forecast By 2021 To 2030
12 Oct 2021 19:52 GMT
… Market:
Global Glioblastoma Treatment Market Revenue and Forecast, by Drugs
Bevacizumab (Avastin … MM-398
ARC-100
AV0113
Cotara
Crenolanib
SGT-53
Endostatin
ANG1005 … distinct insights, namely, Glioblastoma Multiforme Treatment (GBM) industry trends, growth …
-
Global Cancer Monoclonal Antibodies Market & Clinical Trial Insight Report 2018-2024: 697 mAb in the Pipeline & 60 Marketed Cancer Monoclonal Antibodies
20 Nov 2018 11:35 GMT
… Trial Insight 2024 Report Highlights: Significance for Monoclonal Antibodies for Cancer Treatment
Global Cancer … has enabled the pharmaceutical companies to … 131 Derlotuximab Biotin (Cotara)
27.3 Bevacizumab … Disorders Drugs, Clinical Trials, Biopharmaceuticals
-
Peregrine Pharmaceuticals (PPHM) Downgraded by Zacks Investment Research
08 May 2017 18:01 GMT
… clinical trials for the treatment of cancer and … cancer and HCV infection with its lead product candidate bavituximab and Cotara … stock.
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc (Peregrine … supporting its internal drug development efforts. …